{"id":2036,"date":"2026-11-01T11:21:47","date_gmt":"2026-11-01T10:21:47","guid":{"rendered":"https:\/\/doktorpeptid.sk\/bpc-157-a-tb-500-co-robi-ktory-peptid\/"},"modified":"2026-11-01T15:57:53","modified_gmt":"2026-11-01T14:57:53","slug":"bpc-157-a-tb-500-co-robi-ktory-peptid","status":"publish","type":"post","link":"https:\/\/doktorpeptid.sk\/en\/bpc-157-a-tb-500-co-robi-ktory-peptid\/","title":{"rendered":"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum"},"content":{"rendered":"<style>\n.dp-lead{font-size:1.15em;line-height:1.7;color:#1b2440}\n.dp-note{background:#f3f6ff;border:1px solid #d9e2ff;border-left:4px solid #1f5bff;border-radius:12px;padding:16px 20px;margin:24px 0;font-size:.95em;color:#24304f}\n.dp-note--end{border-left-color:#ff4d5e;background:#fff5f6;border-color:#ffd9de}\n.dp-table-wrap{overflow-x:auto;margin:20px 0 28px;border:1px solid #e3e8f2;border-radius:14px}\n.dp-table{width:100%;border-collapse:collapse;font-size:.95em;margin:0}\n.dp-table th{background:#0b1530;color:#fff;text-align:left;padding:12px 14px;font-weight:700}\n.dp-table th:nth-child(2){color:#7fd6ff}.dp-table th:nth-child(3){color:#ffc56b}\n.dp-table td{padding:11px 14px;border-top:1px solid #e9edf5;vertical-align:top}\n.dp-table td:first-child{font-weight:700;color:#1b2440;white-space:nowrap;background:#f8faff}\n.dp-fig{margin:28px auto;text-align:center}\n.dp-fig img{border-radius:16px;max-width:100%;height:auto;box-shadow:0 12px 40px rgba(11,21,48,.18)}\n.dp-fig--formula img{background:#fff;padding:18px;box-shadow:none;border:1px solid #e3e8f2;max-height:420px;width:auto}\n.dp-fig figcaption{font-size:.85em;color:#6b7690;margin-top:10px}\n.dp-cards{display:grid;grid-template-columns:repeat(auto-fit,minmax(220px,1fr));gap:16px;margin:20px 0}\n.dp-card{border-radius:16px;padding:20px 22px;color:#fff}\n.dp-card p{margin:8px 0 0;color:rgba(255,255,255,.88);font-size:.95em}\n.dp-card--blue{background:linear-gradient(135deg,#0b2a6b,#1f5bff)}.dp-card--gold{background:linear-gradient(135deg,#5a3200,#d98a12)}\n.dp-card__k{font-size:.8em;letter-spacing:.12em;text-transform:uppercase;opacity:.8}.dp-card__t{font-size:1.35em;font-weight:800;margin-top:2px}\n.dp-product{display:grid;grid-template-columns:repeat(auto-fit,minmax(180px,1fr));gap:12px;margin:22px 0}\n.dp-product__card{display:flex;flex-direction:column;gap:4px;padding:16px 18px;border:1px solid #dfe5f1;border-radius:14px;text-decoration:none!important;color:#0b1530!important;transition:.2s}\n.dp-product__card:hover{border-color:#1f5bff;box-shadow:0 8px 24px rgba(31,91,255,.15);transform:translateY(-2px)}\n.dp-product__k{font-size:.75em;text-transform:uppercase;letter-spacing:.1em;color:#1f5bff;font-weight:700}.dp-product__t{font-weight:800}.dp-product__s{font-size:.85em;color:#6b7690}\n.dp-product br,.dp-cards br{display:none}\n.dp-sources{font-size:.88em;color:#46506a}.dp-sources li{margin-bottom:6px}\n<\/style>\n<p class=\"dp-lead\">BPC-157 a TB-500 sa v online komunite takmer v\u017edy spom\u00ednaj\u00fa spolu. Kombin\u00e1cia dostala aj prez\u00fdvku \u201eWolverine blend\u201c pod\u013ea komiksovej postavy, ktorej sa rany hoja sam\u00e9 od seba. Za marketingovou n\u00e1lepkou s\u00fa v\u0161ak dve \u00faplne odli\u0161n\u00e9 molekuly, s odli\u0161n\u00fdm p\u00f4vodom, mechanizmom aj mno\u017estvom d\u00e1t. V tomto \u010dl\u00e1nku rozober\u00e1me, odkia\u013e sa vzali, \u010do o nich hovoria \u0161t\u00fadie na zvierat\u00e1ch aj na \u013eu\u010foch, pre\u010do sa sk\u00famaj\u00fa spolu a ak\u00fd je ich regula\u010dn\u00fd status na konci roka 2026.<\/p>\n<div class=\"dp-note\"><strong>D\u00f4le\u017eit\u00e9:<\/strong> \u010cl\u00e1nok m\u00e1 v\u00fdlu\u010dne eduka\u010dn\u00fd a informa\u010dn\u00fd charakter. Nie je to zdravotn\u00e1 rada ani n\u00e1vod na pou\u017eitie. BPC-157 ani TB-500 nie s\u00fa v E\u00da schv\u00e1len\u00e9 ako lieky a produkty DoktorPeptid s\u00fa ur\u010den\u00e9 iba na laborat\u00f3rny v\u00fdskum.<\/div>\n<h2>R\u00fdchly preh\u013ead: BPC-157 vs. TB-500<\/h2>\n<div class=\"dp-table-wrap\">\n<table class=\"dp-table\">\n<thead>\n<tr>\n<th><\/th>\n<th>BPC-157<\/th>\n<th>TB-500<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>P\u00f4vod<\/td>\n<td>Syntetick\u00fd \u00fasek prote\u00ednu z \u013eudskej \u017eal\u00fado\u010dnej \u0161\u0165avy<\/td>\n<td>Syntetick\u00e1 k\u00f3pia \u00faseku 17\u201323 prote\u00ednu tymoz\u00edn beta-4<\/td>\n<\/tr>\n<tr>\n<td>D\u013a\u017eka<\/td>\n<td>15 aminokysel\u00edn (pentadekapeptid)<\/td>\n<td>7 aminokysel\u00edn (heptapeptid)<\/td>\n<\/tr>\n<tr>\n<td>Sekvencia<\/td>\n<td>GEPPPGKPADDAGLV<\/td>\n<td>Ac-LKKTETQ<\/td>\n<\/tr>\n<tr>\n<td>Sum\u00e1rny vzorec<\/td>\n<td>C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<td>C<sub>38<\/sub>H<sub>68<\/sub>N<sub>10<\/sub>O<sub>14<\/sub><\/td>\n<\/tr>\n<tr>\n<td>Mol\u00e1rna hmotnos\u0165<\/td>\n<td>\u2248 1419,6 g\/mol<\/td>\n<td>\u2248 889,0 g\/mol<\/td>\n<\/tr>\n<tr>\n<td>Hlavn\u00e1 sk\u00faman\u00e1 t\u00e9ma<\/td>\n<td>Tvorba nov\u00fdch ciev (angiogen\u00e9za), ochrana sliznice, hojenie \u0161liach<\/td>\n<td>V\u00e4zba na akt\u00edn a pohyb (migr\u00e1cia) buniek<\/td>\n<\/tr>\n<tr>\n<td>D\u00e1ta na \u013eu\u010foch<\/td>\n<td>Len nieko\u013eko mal\u00fdch \u0161t\u00fadi\u00ed<\/td>\n<td>Fragment netestovan\u00fd; cel\u00fd tymoz\u00edn \u03b24 pre\u0161iel klinick\u00fdmi \u0161t\u00fadiami f\u00e1zy 2<\/td>\n<\/tr>\n<tr>\n<td>WADA<\/td>\n<td>Zak\u00e1zan\u00fd (kateg\u00f3ria S0, od 2022)<\/td>\n<td>Zak\u00e1zan\u00fd<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<figure class=\"dp-fig\"><img decoding=\"async\" class=\"wp-image-2031\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce.jpg\" alt=\"Re\u0165azce aminokysel\u00edn BPC-157 a TB-500\" width=\"900\" height=\"900\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce.jpg 900w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-300x300.jpg 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-150x150.jpg 150w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-768x768.jpg 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-12x12.jpg 12w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-700x700.jpg 700w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-600x600.jpg 600w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-retazce-100x100.jpg 100w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><figcaption>Ilustr\u00e1cia DoktorPeptid: 15-\u010dl\u00e1nkov\u00fd re\u0165azec BPC-157 (modr\u00fd) a 7-\u010dl\u00e1nkov\u00fd TB-500 (zlat\u00fd) s jednop\u00edsmenov\u00fdmi k\u00f3dmi aminokysel\u00edn.<\/figcaption><\/figure>\n<h2>BPC-157: peptid zo \u017eal\u00fado\u010dnej \u0161\u0165avy<\/h2>\n<h3>Ako vznikol<\/h3>\n<p>BPC-157 (Body Protection Compound 157, v literat\u00fare aj <em>bepecin<\/em> alebo k\u00f3dom PL 14736) objavil chorv\u00e1tsky farmakol\u00f3g <strong>Predrag Sikiri\u0107<\/strong> z Lek\u00e1rskej fakulty Univerzity v Z\u00e1hrebe. Prv\u00e9 pr\u00e1ce publikoval v roku 1993. Peptid je odvoden\u00fd od prote\u00ednu, ktor\u00fd sa prirodzene nach\u00e1dza v \u013eudskej \u017eal\u00fado\u010dnej \u0161\u0165ave. Samotn\u00e1 zl\u00fa\u010denina, s ktorou sa pracuje v laborat\u00f3ri\u00e1ch, je v\u0161ak syntetick\u00e1.<\/p>\n<p>Jeho sekvencia je <strong>Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val<\/strong>. Zauj\u00edmav\u00e1 je jeho stabilita: v \u013eudskej \u017eal\u00fado\u010dnej \u0161\u0165ave vydr\u017e\u00ed neporu\u0161en\u00fd viac ako 24 hod\u00edn, \u010do je pri peptidoch nezvy\u010dajn\u00e9. Na druhej strane, u potkanov m\u00e1 po podan\u00ed do \u017eily \u010di svalu pol\u010das rozpadu iba pribli\u017ene 8 a\u017e 30 min\u00fat. Metabolizuje sa v pe\u010deni a vylu\u010duje obli\u010dkami.<\/p>\n<p>V 90. rokoch a za\u010diatkom 2000-t\u00fdch rokov ho vyv\u00edjala chorv\u00e1tska farmaceutick\u00e1 spolo\u010dnos\u0165 Pliva pod k\u00f3dom PL 14736 so z\u00e1merom lie\u010dby z\u00e1palov\u00fdch ochoren\u00ed \u010driev. Na schv\u00e1len\u00fd liek to v\u0161ak nikdy nedotiahol.<\/p>\n<figure class=\"dp-fig dp-fig--formula\"><img decoding=\"async\" class=\"wp-image-2029\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec.png\" alt=\"\u0160trukt\u00farny vzorec BPC-157\" width=\"1280\" height=\"657\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec.png 1280w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec-300x154.png 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec-1024x526.png 1024w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec-768x395.png 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec-18x9.png 18w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-strukturny-vzorec-1200x617.png 1200w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><figcaption>\u0160trukt\u00farny vzorec BPC-157. Zdroj: Wikimedia Commons (Innerstream), verejn\u00e9 vlastn\u00edctvo.<\/figcaption><\/figure>\n<h3>\u010co ukazuj\u00fa \u0161t\u00fadie na zvierat\u00e1ch<\/h3>\n<figure class=\"dp-fig\"><img decoding=\"async\" class=\"wp-image-2032\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia.jpg\" alt=\"Natrhnut\u00e1 Achillova \u0161\u013eacha \u2013 ilustr\u00e1cia\" width=\"900\" height=\"900\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia.jpg 900w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-300x300.jpg 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-150x150.jpg 150w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-768x768.jpg 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-12x12.jpg 12w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-700x700.jpg 700w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-600x600.jpg 600w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/natrhnuta-slacha-ilustracia-100x100.jpg 100w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><figcaption>Ilustr\u00e1cia DoktorPeptid: natrhnut\u00e1 Achillova \u0161\u013eacha, typick\u00fd model v \u0161t\u00fadi\u00e1ch hojenia \u0161liach.<\/figcaption><\/figure>\n<p>Preva\u017en\u00e1 v\u00e4\u010d\u0161ina v\u00fdskumu BPC-157 poch\u00e1dza z pokusov na potkanoch a my\u0161iach, z ve\u013ekej \u010dasti od p\u00f4vodnej z\u00e1hrebskej skupiny. Opakuj\u00face sa zistenia:<\/p>\n<ul>\n<li><strong>\u0160\u013eachy a v\u00e4zy:<\/strong> v klasickej \u0161t\u00fadii z roku 2003 ur\u00fdchlil hojenie preru\u0161enej Achillovej \u0161\u013eachy u potkanov a v laborat\u00f3riu podporil rast buniek \u0161\u013eachy (tenocytov). Podobn\u00e9 v\u00fdsledky boli hl\u00e1sen\u00e9 aj pri v\u00e4zoch.<\/li>\n<li><strong>Migr\u00e1cia buniek \u0161\u013eachy:<\/strong> pr\u00e1ca z roku 2011 uk\u00e1zala, \u017ee BPC-157 podporuje prerastanie, pre\u017e\u00edvanie a migr\u00e1ciu fibroblastov \u0161\u013eachy.<\/li>\n<li><strong>Tvorba ciev:<\/strong> viacer\u00e9 modely nazna\u010duj\u00fa, \u017ee podporuje angiogen\u00e9zu, teda vrastanie nov\u00fdch ciev do po\u0161koden\u00e9ho tkaniva.<\/li>\n<li><strong>Tr\u00e1viaci trakt:<\/strong> p\u00f4vodn\u00e1 oblas\u0165 v\u00fdskumu, ktor\u00e1 zah\u0155\u0148a ochranu sliznice a modely vredov a z\u00e1palu.<\/li>\n<\/ul>\n<figure class=\"dp-fig\"><img decoding=\"async\" class=\"wp-image-2033\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia.jpg\" alt=\"BPC-157 a vrastanie nov\u00fdch ciev do rany \u2013 ilustr\u00e1cia\" width=\"900\" height=\"900\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia.jpg 900w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-300x300.jpg 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-150x150.jpg 150w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-768x768.jpg 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-12x12.jpg 12w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-700x700.jpg 700w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-600x600.jpg 600w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-angiogeneza-ilustracia-100x100.jpg 100w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><figcaption>Zjednodu\u0161en\u00e1 ilustr\u00e1cia hypot\u00e9zy: nov\u00e9 cievy vrastaj\u00fa do po\u0161koden\u00e9ho tkaniva.<\/figcaption><\/figure>\n<p>Systematick\u00fd preh\u013ead z roku 2025 (HSS Journal) pre\u0161iel 544 publik\u00e1ci\u00ed z rokov 1993 a\u017e 2024 a do anal\u00fdzy zaradil 36 \u0161t\u00fadi\u00ed. <strong>35 z nich bolo predklinick\u00fdch a iba jedna klinick\u00e1.<\/strong> Autori kon\u0161tatuj\u00fa, \u017ee v predklinick\u00fdch modeloch BPC-157 zlep\u0161oval funk\u010dn\u00e9, \u0161truktur\u00e1lne a biomechanick\u00e9 v\u00fdsledky pri poraneniach svalov, \u0161liach, v\u00e4zov a kost\u00ed. Klinick\u00e9 d\u00e1ta o bezpe\u010dnosti v\u0161ak nena\u0161li.<\/p>\n<h3>\u010co vieme o \u013eu\u010foch<\/h3>\n<p>D\u00e1ta z \u013eudsk\u00fdch \u0161t\u00fadi\u00ed s\u00fa zatia\u013e ve\u013emi skromn\u00e9:<\/p>\n<ul>\n<li><strong>Retrospekt\u00edvna \u0161t\u00fadia (2021):<\/strong> 12 pacientov s chronickou boles\u0165ou kolena dostalo injekciu do k\u013abu a 7 z nich uviedlo \u00fa\u013eavu dlh\u0161iu ako 6 mesiacov. I\u0161lo o mal\u00fa \u0161t\u00fadiu bez kontrolnej skupiny.<\/li>\n<li><strong>Pilotn\u00e1 \u0161t\u00fadia (2024):<\/strong> mal\u00fd s\u00fabor pacientov s interstici\u00e1lnou cystit\u00eddou (z\u00e1palom mo\u010dov\u00e9ho mech\u00fara).<\/li>\n<li><strong>\u0160t\u00fadia f\u00e1zy I<\/strong> na zdrav\u00fdch dobrovo\u013en\u00edkoch, ktorej v\u00fdsledky neboli zverejnen\u00e9.<\/li>\n<\/ul>\n<p>\u00daprimne povedan\u00e9: BPC-157 je dobre presk\u00faman\u00fd na zvierat\u00e1ch, ale na \u013eu\u010foch zatia\u013e nem\u00e1me kvalitn\u00e9 randomizovan\u00e9 \u0161t\u00fadie. Odborn\u00e9 preh\u013eady z\u00e1rove\u0148 upozor\u0148uj\u00fa na teoretick\u00e9 riziko. L\u00e1tka, ktor\u00e1 podporuje rast ciev, by mohla podpori\u0165 aj rast nezachyten\u00fdch n\u00e1dorov. Toto riziko zatia\u013e nikto na \u013eu\u010foch systematicky neoveril.<\/p>\n<h2>TB-500 a tymoz\u00edn beta-4<\/h2>\n<h3>Od \u201ehorm\u00f3nu t\u00fdmusu\u201c k akt\u00ednu<\/h3>\n<p>Na pochopenie TB-500 treba za\u010da\u0165 pri jeho \u201erodi\u010dovi\u201c. <strong>Tymoz\u00edn beta-4 (T\u03b24)<\/strong> je mal\u00fd prote\u00edn (43 aminokysel\u00edn v zrelej forme), ktor\u00fd k\u00f3duje g\u00e9n <em>TMSB4X<\/em> na chromoz\u00f3me X. Izolovali ho z frakcie t\u00fdmusu, takzvanej \u201eThymosin Fraction 5\u201c, ktor\u00fa sk\u00famala skupina Allana Goldsteina. Jeho \u00fapln\u00fa sekvenciu publikovali v roku 1981. P\u00f4vodne sa pova\u017eoval za horm\u00f3n t\u00fdmusu.<\/p>\n<p>Nesk\u00f4r sa uk\u00e1zalo, \u017ee T\u03b24 je v skuto\u010dnosti jedn\u00fdm z najroz\u0161\u00edrenej\u0161\u00edch prote\u00ednov v bunk\u00e1ch. V mnoh\u00fdch tkaniv\u00e1ch dosahuje koncentr\u00e1ciu a\u017e 0,5 mM. Jeho hlavnou \u00falohou je viaza\u0165 vo\u013en\u00fd (globul\u00e1rny) <strong>akt\u00edn<\/strong>, teda stavebn\u00fa jednotku bunkovej \u201ekostry\u201c. Funguje ako z\u00e1sobn\u00edk akt\u00ednu: dr\u017e\u00ed ho pripraven\u00fd a uvo\u013e\u0148uje ho, ke\u010f bunka potrebuje stava\u0165 vl\u00e1kna, napr\u00edklad ke\u010f sa pohybuje.<\/p>\n<h3>\u010co je TB-500<\/h3>\n<p>V sekvencii T\u03b24 je \u00fasek <strong>LKKTET<\/strong> (za\u010d\u00edna na 17. aminokyseline), ktor\u00fd je zachovan\u00fd u v\u0161etk\u00fdch \u03b2-tymoz\u00ednov a ozna\u010duje sa ako akt\u00edn-via\u017euci mot\u00edv. <strong>TB-500 je syntetick\u00fd, N-acetylovan\u00fd \u00fasek 17\u201323, teda Ac-LKKTETQ.<\/strong> Ide o sedem aminokysel\u00edn vystrihnut\u00fdch z \u201eakt\u00edvneho\u201c miesta v\u00e4\u010d\u0161ieho prote\u00ednu.<\/p>\n<figure class=\"dp-fig dp-fig--formula\"><img decoding=\"async\" class=\"wp-image-2030\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb-500-strukturny-vzorec.png\" alt=\"\u0160trukt\u00farny vzorec TB-500\" width=\"567\" height=\"799\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb-500-strukturny-vzorec.png 567w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb-500-strukturny-vzorec-213x300.png 213w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb-500-strukturny-vzorec-9x12.png 9w\" sizes=\"auto, (max-width: 567px) 100vw, 567px\" \/><figcaption>\u0160trukt\u00fara TB-500 (Ac-LKKTETQ). Zdroj: Wikimedia Commons (Meodipt), verejn\u00e9 vlastn\u00edctvo.<\/figcaption><\/figure>\n<p>Kry\u0161talografick\u00e9 modely z\u00e1rove\u0148 ukazuj\u00fa, \u017ee s akt\u00ednom v skuto\u010dnosti interaguje takmer cel\u00e1 d\u013a\u017eka T\u03b24, nielen tento kr\u00e1tky mot\u00edv. \u010ci m\u00e1 samotn\u00fd 7-aminokyselinov\u00fd fragment rovnak\u00e9 \u00fa\u010dinky ako cel\u00fd prote\u00edn, preto zost\u00e1va otvorenou ot\u00e1zkou.<\/p>\n<figure class=\"dp-fig\"><img decoding=\"async\" class=\"wp-image-2034\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia.jpg\" alt=\"TB-500 naviazan\u00fd na akt\u00edn \u2013 ilustr\u00e1cia\" width=\"900\" height=\"900\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia.jpg 900w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-300x300.jpg 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-150x150.jpg 150w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-768x768.jpg 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-12x12.jpg 12w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-700x700.jpg 700w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-600x600.jpg 600w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/tb500-aktin-ilustracia-100x100.jpg 100w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><figcaption>Ilustr\u00e1cia: 7-\u010dl\u00e1nkov\u00fd fragment LKKTETQ sa via\u017ee na akt\u00edn, stavebn\u00fa bielkovinu bunkovej \u201ekostry\u201c.<\/figcaption><\/figure>\n<h3>\u010co ukazuj\u00fa \u0161t\u00fadie<\/h3>\n<p>Kult\u00fary buniek a pokusy na zvierat\u00e1ch opakovane ukazuj\u00fa, \u017ee T\u03b24 podporuje <strong>migr\u00e1ciu buniek<\/strong> (napr. \u013eudsk\u00fdch endotelov\u00fdch buniek z pupo\u010dn\u00edkovej \u017eily u\u017e v \u0161t\u00fadii z roku 1997), tvorbu ciev a pre\u017e\u00edvanie buniek. Z\u00e1rove\u0148 zni\u017euje tvorbu proz\u00e1palov\u00fdch cytok\u00ednov. V my\u0161ac\u00edch modeloch sa sk\u00famal aj pri obnove srdcov\u00e9ho svalu po infarkte (Nature, 2011).<\/p>\n<p>Na rozdiel od BPC-157 m\u00e1 <strong>cel\u00fd tymoz\u00edn \u03b24 za sebou aj klinick\u00e9 \u0161t\u00fadie na \u013eu\u010foch:<\/strong><\/p>\n<ul>\n<li><strong>Ven\u00f3zne vredy (f\u00e1za 2):<\/strong> dvojito zaslepen\u00e1, placebom kontrolovan\u00e1 \u0161t\u00fadia na 73 pacientoch v Taliansku a Po\u013esku. Bezpe\u010dnos\u0165 bola porovnate\u013en\u00e1 s placebom a d\u00e1vka 0,03 % nazna\u010dila potenci\u00e1l ur\u00fdchli\u0165 hojenie.<\/li>\n<li><strong>Prele\u017eaniny a epidermolysis bullosa (f\u00e1za 2):<\/strong> hl\u00e1sen\u00e9 zr\u00fdchlenie hojenia a dobr\u00e1 zn\u00e1\u0161anlivos\u0165.<\/li>\n<li><strong>O\u010di:<\/strong> o\u010dn\u00e9 kvapky s T\u03b24 sa sk\u00famali pri syndr\u00f3me such\u00e9ho oka a neurotrofickej keratopatii.<\/li>\n<\/ul>\n<p>Pre <strong>samotn\u00fd TB-500<\/strong> v\u0161ak klinick\u00e9 \u0161t\u00fadie na \u013eu\u010foch neexistuj\u00fa. Jeho hist\u00f3ria je sk\u00f4r \u201e\u0161portov\u00e1\u201c. Objavoval sa ako dopingov\u00e1 l\u00e1tka hlavne v konsk\u00fdch dostihoch a laborat\u00f3ri\u00e1 vyvinuli met\u00f3dy na jeho detekciu v mo\u010di a plazme kon\u00ed. Tymoz\u00edn \u03b24 bol z\u00e1rove\u0148 v centre dvoch ve\u013ek\u00fdch dopingov\u00fdch k\u00e1uz v austr\u00e1lskom \u0161porte v 2010-tych rokoch.<\/p>\n<h2>Pre\u010do sa sk\u00famaj\u00fa spolu<\/h2>\n<p>Logika \u201eWolverine blendu\u201c vych\u00e1dza z toho, \u017ee hojenie potrebuje dve veci naraz:<\/p>\n<div class=\"dp-cards\">\n<div class=\"dp-card dp-card--blue\">\n<div class=\"dp-card__k\">BPC-157<\/div>\n<div class=\"dp-card__t\">\u201estavia cesty\u201c<\/div>\n<p>Hypot\u00e9za: podporuje vrastanie nov\u00fdch ciev, ktor\u00e9 prived\u00fa do rany kysl\u00edk a \u017eiviny.<\/p>\n<\/div>\n<div class=\"dp-card dp-card--gold\">\n<div class=\"dp-card__k\">TB-500<\/div>\n<div class=\"dp-card__t\">\u201eposiela robotn\u00edkov\u201c<\/div>\n<p>Hypot\u00e9za: cez akt\u00edn podporuje pohyb buniek, ktor\u00e9 sa presun\u00fa do po\u0161koden\u00e9ho miesta a opravuj\u00fa ho.<\/p>\n<\/div>\n<\/div>\n<figure class=\"dp-fig\"><img decoding=\"async\" class=\"wp-image-2035\" src=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia.jpg\" alt=\"Cievy a migruj\u00face bunky v rane \u2013 ilustr\u00e1cia\" width=\"900\" height=\"900\" loading=\"lazy\"  title=\"BPC-157 a TB-500: \u010do rob\u00ed ktor\u00fd peptid a \u010do o nich hovor\u00ed v\u00fdskum\" srcset=\"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia.jpg 900w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-300x300.jpg 300w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-150x150.jpg 150w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-768x768.jpg 768w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-12x12.jpg 12w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-700x700.jpg 700w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-600x600.jpg 600w, https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc157-tb500-hojenie-rany-ilustracia-100x100.jpg 100w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><figcaption>Ilustr\u00e1cia: cievy (\u010derven\u00e9) a migruj\u00face bunky (fialov\u00e9) v zjednodu\u0161enom reze ranou.<\/figcaption><\/figure>\n<p>Znie to logicky, no treba poveda\u0165 jasne: <strong>nepozn\u00e1me publikovan\u00fa klinick\u00fa \u0161t\u00fadiu, ktor\u00e1 by sk\u00famala samotn\u00fa kombin\u00e1ciu BPC-157 + TB-500 na \u013eu\u010foch.<\/strong> Synergia je zatia\u013e hypot\u00e9za postaven\u00e1 na mechanizmoch z predklinick\u00fdch \u0161t\u00fadi\u00ed.<\/p>\n<h2>Regul\u00e1cia a aktuality (november 2026)<\/h2>\n<ul>\n<li><strong>WADA:<\/strong> BPC-157 je od roku 2022 zak\u00e1zan\u00fd v kateg\u00f3rii S0 (neschv\u00e1len\u00e9 l\u00e1tky). Zak\u00e1zan\u00e9 s\u00fa aj TB-500 a tymoz\u00edn \u03b24.<\/li>\n<li><strong>Austr\u00e1lia a Nov\u00fd Z\u00e9land<\/strong> ich zaradili medzi lieky na predpis, hoci leg\u00e1lne na predpis dostupn\u00e9 nie s\u00fa.<\/li>\n<li><strong>USA, okt\u00f3ber 2026:<\/strong> americk\u00e9 ministerstvo zdravotn\u00edctva (HHS) 28. okt\u00f3bra ozn\u00e1milo, \u017ee nebude zasahova\u0165 proti mal\u00fdm kompaunda\u010dn\u00fdm lek\u00e1r\u0148am (503A), ktor\u00e9 bud\u00fa pripravova\u0165 \u0161es\u0165 peptidov: BPC-157, TB-500, Epitalon, KPV, MOTS-c a Semax. FDA ich ani tak neschv\u00e1lila. Vlastn\u00ed vedci FDA odpor\u00fa\u010dali re\u0161trikcie ponecha\u0165 a spotrebite\u013esk\u00e9 organiz\u00e1cie rozhodnutie kritizuj\u00fa.<\/li>\n<li><strong>E\u00da a Slovensko:<\/strong> ani jedna z l\u00e1tok nie je registrovan\u00e1 ako liek.<\/li>\n<\/ul>\n<h2>Kvalita materi\u00e1lu vo v\u00fdskume<\/h2>\n<p>Pri v\u00fdskume akejko\u013evek l\u00e1tky stoja v\u00fdsledky na kvalite materi\u00e1lu: identite, \u010distote a deklarovanom mno\u017estve. Preto ku ka\u017edej \u0161ar\u017ei zverej\u0148ujeme <a href=\"\/en\/coa\/\">COA dokument\u00e1ciu<\/a>.<\/p>\n<div class=\"dp-product\">\n<a class=\"dp-product__card\" href=\"\/en\/product\/bpc-157-tb-500\/\"><span class=\"dp-product__k\">V\u00fdskumn\u00e1 zmes<\/span><span class=\"dp-product__t\">BPC-157 + TB-500 \u00b7 10 mg<\/span><span class=\"dp-product__s\">5 mg + 5 mg \u00b7 iba na v\u00fdskum<\/span><\/a><a class=\"dp-product__card\" href=\"\/en\/product\/bpc-157\/\"><span class=\"dp-product__k\">Samostatne<\/span><span class=\"dp-product__t\">BPC-157 \u00b7 5 \/ 10 mg<\/span><span class=\"dp-product__s\">iba na v\u00fdskum<\/span><\/a><a class=\"dp-product__card\" href=\"\/en\/product\/tb-500\/\"><span class=\"dp-product__k\">Samostatne<\/span><span class=\"dp-product__t\">TB-500 \u00b7 5 mg<\/span><span class=\"dp-product__s\">iba na v\u00fdskum<\/span><\/a>\n<\/div>\n<h2>Frequently asked questions<\/h2>\n<h3>Je BPC-157 to ist\u00e9 ako TB-500?<\/h3>\n<p>Nie. BPC-157 je 15-aminokyselinov\u00fd peptid odvoden\u00fd od prote\u00ednu zo \u017eal\u00fado\u010dnej \u0161\u0165avy. TB-500 je 7-aminokyselinov\u00fd \u00fasek prote\u00ednu tymoz\u00edn \u03b24. Maj\u00fa in\u00fd p\u00f4vod aj in\u00fd sk\u00faman\u00fd mechanizmus.<\/p>\n<h3>Je TB-500 to ist\u00e9 ako tymoz\u00edn beta-4?<\/h3>\n<p>Nie celkom. Tymoz\u00edn \u03b24 je cel\u00fd prote\u00edn so 43 aminokyselinami. TB-500 je iba jeho kr\u00e1tky syntetick\u00fd fragment (aminokyseliny 17\u201323). Klinick\u00e9 \u0161t\u00fadie f\u00e1zy 2 sa robili s cel\u00fdm T\u03b24, nie s TB-500.<\/p>\n<h3>Testoval sa BPC-157 na \u013eu\u010foch?<\/h3>\n<p>Len vo ve\u013emi obmedzenej miere: mal\u00e1 retrospekt\u00edvna \u0161t\u00fadia (12 pacientov), pilotn\u00e1 \u0161t\u00fadia a nezverejnen\u00e1 f\u00e1za I. V\u00e4\u010d\u0161ina d\u00e1t poch\u00e1dza zo \u0161t\u00fadi\u00ed na zvierat\u00e1ch.<\/p>\n<h3>Existuje \u0161t\u00fadia kombin\u00e1cie BPC-157 + TB-500?<\/h3>\n<p>Klinick\u00fa \u0161t\u00fadiu kombin\u00e1cie na \u013eu\u010foch nepozn\u00e1me. My\u0161lienka spolo\u010dn\u00e9ho p\u00f4sobenia vych\u00e1dza z odli\u0161n\u00fdch mechanizmov pop\u00edsan\u00fdch v predklinickom v\u00fdskume.<\/p>\n<h2>Zdroje<\/h2>\n<ol class=\"dp-sources\">\n<li>Vasireddi N. a kol. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. <em>HSS Journal<\/em>, 2025. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40756949\/\" target=\"_blank\" rel=\"noopener\">PubMed 40756949<\/a><\/li>\n<li>Staresinic M. a kol. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. <em>J Orthop Res<\/em>, 2003. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14554208\/\" target=\"_blank\" rel=\"noopener\">PubMed 14554208<\/a><\/li>\n<li>Chang C.H. a kol. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. <em>J Appl Physiol<\/em>, 2011. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\" target=\"_blank\" rel=\"noopener\">PubMed 21030672<\/a><\/li>\n<li>Lee E., Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. <em>Altern Ther Health Med<\/em>, 2021. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34324435\/\" target=\"_blank\" rel=\"noopener\">PubMed 34324435<\/a><\/li>\n<li>J\u00f3zwiak M. a kol. Multifunctionality and Possible Medical Application of the BPC 157 Peptide. <em>Pharmaceuticals<\/em>, 2025. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40005999\/\" target=\"_blank\" rel=\"noopener\">PubMed 40005999<\/a><\/li>\n<li>Low T.L., Hu S.K., Goldstein A.L. Complete amino acid sequence of bovine thymosin beta 4. <em>PNAS<\/em>, 1981. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/6940133\/\" target=\"_blank\" rel=\"noopener\">PubMed 6940133<\/a><\/li>\n<li>Van Troys M. a kol. The actin binding site of thymosin beta 4 mapped by mutational analysis. <em>EMBO J<\/em>, 1996. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8617195\/\" target=\"_blank\" rel=\"noopener\">PubMed 8617195<\/a><\/li>\n<li>Esposito S. a kol. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500. <em>Drug Test Anal<\/em>, 2012. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22962027\/\" target=\"_blank\" rel=\"noopener\">PubMed 22962027<\/a><\/li>\n<li>Malinda K.M. a kol. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. <em>FASEB J<\/em>, 1997. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9194528\/\" target=\"_blank\" rel=\"noopener\">PubMed 9194528<\/a><\/li>\n<li>Guarnera G. a kol. The effect of thymosin treatment of venous ulcers. <em>Ann N Y Acad Sci<\/em>, 2010. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20536470\/\" target=\"_blank\" rel=\"noopener\">PubMed 20536470<\/a><\/li>\n<li>Sosne G., Kleinman H.K. Primary Mechanisms of Thymosin \u03b24 Repair Activity in Dry Eye Disorders and Other Tissue Injuries. <em>IOVS<\/em>, 2015. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26241398\/\" target=\"_blank\" rel=\"noopener\">PubMed 26241398<\/a><\/li>\n<li>Lupkin S. Trump administration will allow pharmacies to make popular peptides. <em>NPR<\/em>, 28. 10. 2026. <a href=\"https:\/\/www.npr.org\/2026\/10\/28\/nx-s1-6021030\/peptides-compounding-enforcement\" target=\"_blank\" rel=\"noopener\">npr.org<\/a><\/li>\n<li>Wikipedia: <a href=\"https:\/\/en.wikipedia.org\/wiki\/BPC-157\" target=\"_blank\" rel=\"noopener\">BPC-157<\/a>, <a href=\"https:\/\/en.wikipedia.org\/wiki\/TB-500\" target=\"_blank\" rel=\"noopener\">TB-500<\/a>, <a href=\"https:\/\/en.wikipedia.org\/wiki\/Thymosin_beta-4\" target=\"_blank\" rel=\"noopener\">Thymosin beta-4<\/a><\/li>\n<\/ol>\n<div class=\"dp-note dp-note--end\">Produkty DoktorPeptid s\u00fa ur\u010den\u00e9 v\u00fdhradne na vedeck\u00e9 a laborat\u00f3rne \u00fa\u010dely. Nie s\u00fa ur\u010den\u00e9 na \u013eudsk\u00fa ani zvieraciu konzum\u00e1ciu, diagnostiku ani lie\u010dbu. Tento \u010dl\u00e1nok nepredstavuje zdravotn\u00fa radu.<\/div>","protected":false},"excerpt":{"rendered":"<p>BPC-157 a TB-500 sa spom\u00ednaj\u00fa ako \u201eWolverine blend\u201c. Pozrime sa, odkia\u013e sa vzali, \u010do o nich hovoria \u0161t\u00fadie na zvierat\u00e1ch aj na \u013eu\u010foch, pre\u010do sa sk\u00famaj\u00fa spolu a ak\u00fd je ich regula\u010dn\u00fd status v roku 2026.<\/p>","protected":false},"author":1,"featured_media":2028,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[102],"tags":[],"class_list":["post-2036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptidy-vo-vyskume"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/doktorpeptid.sk\/wp-content\/uploads\/2026\/11\/bpc-157-tb-500-wolverine-blend.jpg","_links":{"self":[{"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/posts\/2036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/comments?post=2036"}],"version-history":[{"count":2,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/posts\/2036\/revisions"}],"predecessor-version":[{"id":2049,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/posts\/2036\/revisions\/2049"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/media\/2028"}],"wp:attachment":[{"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/media?parent=2036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/categories?post=2036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/doktorpeptid.sk\/en\/wp-json\/wp\/v2\/tags?post=2036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}